3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
pembrolizumab
4
Nivolumab
3
Itraconazole
2
tucatinib
1
tremelimumab
1
regorafenib
1
pertuzumab
1
lenvatinib
1
larotrectinib
1
durvalumab
1
cemiplimab
1
brigimadlin
1
aflibercept
1
Trastuzumab
1
Ritonavir
1
Paclitaxel
1
Fulvestrant
1
Clinical Trials, Phase II as Topic
1
Carboplatin
1
Capecitabine
1
Antibodies
1
AZD9833
1
AZD5305
1
AZD 6244
1
ARX788
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
aflibercept
×
Breast
×
Clear all
NCT01843725
2018-01-31
MOMENTUM1
Jules Bordet Institute
Phase 1
Completed
37 enrolled